Antibiotice plans production for critical medicines
Local pharma producer Antibiotice is planning a significant investment in the research, development, and production of critical medicines, with a proposed RON 376.8 million.
Local pharma producer Antibiotice is planning a significant investment in the research, development, and production of critical medicines, with a proposed RON 376.8 million.
Ceres Pharma, a Belgian pharmaceutical group, has announced the official completion of the integration process between its Romanian subsidiaries, Dacia Plant and Viva Pharma.
Novartis has over 550 employees in Romania and operates a manufacturing unit in the country.
Turnover was approximately RON 231 million in the first nine months of the year.
Opening of STADA production and supply-chain hub in Turda, Romania, strengthens European security of supply with more than 150 million packs of medicines per year.

Apa Nova Bucharest has announced investments exceeding €49 million in 2026 for modernising water and sewerage infrastructure and improving energy efficiency.
The Ministry of Finance raised over RON1.9 billion (€379 million) through its fourth Fidelis government bond offering this year, marking the highest value raised in 2026.
The number of insolvencies in agriculture increased by 181.8% in Q1 2026, with the sector facing its most serious structural imbalance in 30 years, according to an analysis by Infinexa.
Romania continues to record the highest rate of road traffic fatalities in the European Union, according to the latest figures released by Eurostat.
Millennials aged between 30 and 45 contracted almost two-thirds of mortgage loans processed by Ipotecare.ro in 2025, according to an analysis based on over 1,000 intermediated financings and over 27,000 simulations.